Ratings by Wedbush (David Nierengarten)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/16/2021 MacroGenics MGNX Maintain Outperform
(N/A)
 
 
  Details
5/18/2021 Nuvation Bio Inc NUVB Maintain Outperform
(N/A)
 
 
  Details
5/18/2021 Kinnate Biopharma KNTE Maintain Outperform
(N/A)
 
 
  Details
5/12/2021 Cogent COGT Maintain Outperform
(N/A)
 
 
  Details
5/11/2021 Mersana MRSN Maintain Outperform
(N/A)
 
 
  Details
5/7/2021 Chimerix CMRX Maintain Outperform
(N/A)
 
 
  Details
5/7/2021 Fate Therapeutics FATE Upgrade Outperform
(Neutral)
77.73
(80.23)
3.22% Details
5/6/2021 Epizyme EPZM Maintain Outperform
(N/A)
 
 
  Details
5/6/2021 Spring Works Therapeutics SWTX Maintain Outperform
(N/A)
 
 
  Details
4/14/2021 NovoCure Ltd. NVCR Downgrade Neutral
(Outperform)
197.33
(218.04)
10.5% Details
4/13/2021 Blueprint Medicines BPMC Maintain Outperform
(N/A)
 
 
  Details
3/31/2021 Chimerix CMRX New Coverage Outperform
(N/A)
8.59
(8.35)
-2.79% Details
3/25/2021 iTeos Therapeutics ITOS Maintain Outperform
(N/A)
 
 
  Details
3/17/2021 Codiak Biosciences Inc. CDAK Maintain Outperform
(N/A)
 
 
  Details
3/15/2021 Beam Inc BEAM Maintain Outperform
(N/A)
 
 
  Details
3/11/2021 TCR2 Therapeutics TCRR Maintain Outperform
(N/A)
 
 
  Details
3/9/2021 AnaptysBio ANAB Downgrade Neutral
(Outperform)
19.51
(24.33)
24.71% Details
3/8/2021 Nuvation Bio Inc NUVB New Coverage Outperform
(N/A)
10.86
(9.67)
-10.96% Details
2/26/2021 Y-mAbs Therapeutics YMAB Maintain Outperform
(N/A)
 
 
  Details
2/26/2021 Mersana MRSN Maintain Outperform
(N/A)
 
 
  Details
2/26/2021 Fate Therapeutics FATE Downgrade Neutral
(Outperform)
86.27
(80.23)
-7% Details
2/25/2021 Spring Works Therapeutics SWTX Maintain Outperform
(N/A)
 
 
  Details
2/24/2021 Beam Inc BEAM Maintain Outperform
(N/A)
 
 
  Details
2/16/2021 G1 Therapeutics GTHX Maintain Outperform
(N/A)
 
 
  Details
2/16/2021 bluebird bio BLUE Downgrade Neutral
(Outperform)
45.76
(33.15)
-27.56% Details
1/29/2021 Turning Point Therapeutics Inc. TPTX Maintain Outperform
(N/A)
 
 
  Details
12/30/2020 Codiak Biosciences Inc. CDAK Maintain Outperform
(N/A)
 
 
  Details
12/28/2020 Kinnate Biopharma KNTE New Coverage Outperform
(N/A)
38.00
(23.83)
-37.29% Details
12/21/2020 Karyopharm Therapeutics KPTI Maintain Neutral
(N/A)
 
 
  Details
12/17/2020 MacroGenics MGNX Maintain Outperform
(N/A)
 
 
  Details
12/14/2020 TCR2 Therapeutics TCRR Maintain Outperform
(N/A)
 
 
  Details
11/12/2020 Spring Works Therapeutics SWTX Maintain Outperform
(N/A)
 
 
  Details
11/6/2020 Aravive Inc. ARAV Maintain Outperform
(N/A)
 
 
  Details
11/6/2020 Fate Therapeutics FATE Maintain Outperform
(N/A)
 
 
  Details
11/6/2020 Intellia Therapeutics NTLA Maintain Neutral
(N/A)
 
 
  Details
11/5/2020 bluebird bio BLUE Maintain Outperform
(N/A)
 
 
  Details
10/30/2020 Epizyme EPZM Maintain Outperform
(N/A)
 
 
  Details
10/30/2020 Blueprint Medicines BPMC Maintain Outperform
(N/A)
 
 
  Details
10/27/2020 Scholar Rock SRRK Maintain Outperform
(N/A)
 
 
  Details
10/27/2020 AnaptysBio ANAB Upgrade Outperform
(Neutral)
27.73
(24.33)
-12.26% Details
10/19/2020 Intellia Therapeutics NTLA Maintain Neutral
(N/A)
 
 
  Details
10/13/2020 Turning Point Therapeutics Inc. TPTX Maintain Outperform
(N/A)
 
 
  Details
10/5/2020 argenx SE ARGX Maintain Outperform
(N/A)
 
 
  Details
9/22/2020 Blueprint Medicines BPMC Maintain Outperform
(N/A)
 
 
  Details
9/10/2020 Sutro Biopharma STRO Maintain Outperform
(N/A)
 
 
  Details
8/19/2020 Turning Point Therapeutics Inc. TPTX Maintain Outperform
(N/A)
 
 
  Details
8/18/2020 iTeos Therapeutics ITOS New Coverage Outperform
(N/A)
32.92
(25.07)
-23.85% Details
8/18/2020 Inozyme Pharma Inc. INZY Maintain Outperform
(N/A)
 
 
  Details
8/13/2020 Spring Works Therapeutics SWTX Maintain Outperform
(N/A)
 
 
  Details
8/12/2020 Fennec Pharmaceuticals Inc. FENC Maintain Outperform
(N/A)
 
 
  Details
8/7/2020 Syros Pharmaceuticals SYRS Maintain Neutral
(N/A)
 
 
  Details
8/6/2020 Orchard Therapeutics ORTX Maintain Outperform
(N/A)
 
 
  Details
8/6/2020 bluebird bio BLUE Maintain Outperform
(N/A)
 
 
  Details
8/6/2020 G1 Therapeutics GTHX Maintain Outperform
(N/A)
 
 
  Details
8/5/2020 Iveric Bio ISEE Maintain Outperform
(N/A)
 
 
  Details
8/5/2020 Xencor, Inc. XNCR Maintain Outperform
(N/A)
 
 
  Details
8/4/2020 Karyopharm Therapeutics KPTI Maintain Neutral
(N/A)
 
 
  Details
7/31/2020 argenx SE ARGX Maintain Outperform
(N/A)
 
 
  Details
7/31/2020 MacroGenics MGNX Maintain Outperform
(N/A)
 
 
  Details
7/27/2020 TCR2 Therapeutics TCRR Maintain Outperform
(N/A)
 
 
  Details
7/23/2020 Aravive Inc. ARAV Maintain Outperform
(N/A)
 
 
  Details
7/21/2020 Fusion Pharmaceuticals FUSN New Coverage Outperform
(N/A)
15.28
(8.43)
-44.83% Details
7/7/2020 Generation Bio GBIO New Coverage Outperform
(N/A)
19.64
(24.34)
23.93% Details
7/7/2020 Unum Therapeutics UMRX Upgrade Outperform
(Neutral)
2.20
(2.35)
6.82% Details
6/29/2020 Kiniksa KNSA Maintain Outperform
(N/A)
 
 
  Details
6/11/2020 Mersana MRSN Maintain Outperform
(N/A)
 
 
  Details
6/1/2020 Intellia Therapeutics NTLA Maintain Neutral
(N/A)
 
 
  Details
5/27/2020 Mersana MRSN Maintain Outperform
(N/A)
 
 
  Details
5/18/2020 Merus N.V. MRUS Maintain Outperform
(N/A)
 
 
  Details
5/13/2020 Turning Point Therapeutics Inc. TPTX Maintain Outperform
(N/A)
 
 
  Details
5/13/2020 Spring Works Therapeutics SWTX Maintain Outperform
(N/A)
 
 
  Details
5/13/2020 Spring Works Therapeutics SWTX Maintain Outperform
(N/A)
 
 
  Details
5/12/2020 Sutro Biopharma STRO Maintain Outperform
(N/A)
 
 
  Details
5/11/2020 bluebird bio BLUE Maintain Outperform
(N/A)
 
 
  Details
5/11/2020 Y-mAbs Therapeutics YMAB Maintain Outperform
(N/A)
 
 
  Details
5/7/2020 Orchard Therapeutics ORTX Maintain Outperform
(N/A)
 
 
  Details
5/4/2020 Stemline Therapeutics STML Downgrade Neutral
(Outperform)
4.75
(11.83)
149.05% Details
5/1/2020 NovoCure Ltd. NVCR Maintain Neutral
(N/A)
 
 
  Details
4/28/2020 Blueprint Medicines BPMC Maintain Outperform
(N/A)
 
 
  Details
4/3/2020 Fate Therapeutics FATE Maintain Outperform
(N/A)
 
 
  Details
3/26/2020 bluebird bio BLUE Maintain Outperform
(N/A)
 
 
  Details
3/24/2020 Blueprint Medicines BPMC Maintain Outperform
(N/A)
 
 
  Details
3/17/2020 Stemline Therapeutics STML Maintain Outperform
(N/A)
 
 
  Details
3/4/2020 Unum Therapeutics UMRX Downgrade Neutral
(Outperform)
0.53
(2.35)
343.4% Details
3/2/2020 Mersana MRSN Maintain Outperform
(N/A)
 
 
  Details
3/2/2020 Beam Inc BEAM New Coverage Outperform
(N/A)
22.49
(85.00)
277.95% Details
2/27/2020 G1 Therapeutics GTHX Maintain Outperform
(N/A)
 
 
  Details
2/14/2020 Fate Therapeutics FATE Maintain Outperform
(N/A)
 
 
  Details
2/14/2020 Intellia Therapeutics NTLA Downgrade Neutral
(Outperform)
15.51
(75.92)
389.49% Details
2/11/2020 Avrobio Inc. AVRO Maintain Outperform
(N/A)
 
 
  Details
1/24/2020 Epizyme EPZM Maintain Outperform
(N/A)
 
 
  Details
1/23/2020 Applied Genetic Technologies Corp. AGTC Maintain Outperform
(N/A)
 
 
  Details
1/21/2020 MacroGenics MGNX Maintain Outperform
(N/A)
 
 
  Details
1/17/2020 Syros Pharmaceuticals SYRS Downgrade Neutral
(Outperform)
9.20
(5.62)
-38.91% Details
1/17/2020 Karyopharm Therapeutics KPTI Downgrade Neutral
(Outperform)
18.83
(10.58)
-43.81% Details
1/17/2020 Fate Therapeutics FATE Maintain Outperform
(N/A)
 
 
  Details
1/16/2020 Stemline Therapeutics STML Maintain Outperform
(N/A)
 
 
  Details
1/16/2020 Stemline Therapeutics STML Maintain Outperform
(N/A)
 
 
  Details
1/15/2020 Blueprint Medicines BPMC Maintain Outperform
(N/A)
 
 
  Details
1/10/2020 Blueprint Medicines BPMC Maintain Outperform
(N/A)
 
 
  Details
1/7/2020 Iveric Bio ISEE New Coverage Outperform
(N/A)
8.14
(5.87)
-27.89% Details
12/9/2019 argenx SE ARGX Maintain Outperform
(N/A)
 
 
  Details
12/3/2019 Audentes Therapeutics BOLD Downgrade Neutral
(Outperform)
28.61
(59.97)
109.61% Details
11/20/2019 Aravive Inc. ARAV Maintain Outperform
(N/A)
 
 
  Details
11/15/2019 resTORbio Inc. TORC Downgrade Neutral
(Outperform)
7.95
(2.28)
-71.32% Details
11/13/2019 Scholar Rock SRRK Maintain Outperform
(N/A)
 
 
  Details
11/8/2019 AnaptysBio ANAB Downgrade Neutral
(Outperform)
36.16
(24.33)
-32.72% Details
11/4/2019 bluebird bio BLUE Upgrade Outperform
(Neutral)
82.86
(45.76)
-44.77% Details
10/28/2019 Blueprint Medicines BPMC Maintain Outperform
(N/A)
 
 
  Details
10/23/2019 MacroGenics MGNX Maintain Outperform
(N/A)
 
 
  Details
10/8/2019 Spring Works Therapeutics SWTX New Coverage Outperform
(N/A)
18.67
(80.13)
329.19% Details
9/27/2019 Applied Genetic Technologies Corp. AGTC Maintain Outperform
(N/A)
 
 
  Details
9/17/2019 Karyopharm Therapeutics KPTI Maintain Outperform
(N/A)
 
 
  Details
9/10/2019 Turning Point Therapeutics Inc. TPTX New Coverage Outperform
(N/A)
42.75
(81.11)
89.73% Details
9/9/2019 Blueprint Medicines BPMC Maintain Outperform
(N/A)
 
 
  Details
9/4/2019 Y-mAbs Therapeutics Inc. YMAB New Coverage Outperform
()
0.80
(36.22)
4427.5% Details
8/21/2019 Synlogic Inc. SYBX Maintain Outperform
(N/A)
 
 
  Details
8/8/2019 MyoKardia MYOK Maintain Outperform
(N/A)
 
 
  Details
8/7/2019 Xencor, Inc. XNCR Maintain Outperform
(N/A)
 
 
  Details
8/7/2019 Fate Therapeutics FATE Maintain
(N/A)
 
 
  Details
8/2/2019 Stemline Therapeutics STML Upgrade Outperform
(Neutral)
13.03
(4.75)
-63.55% Details
7/26/2019 NovoCure Ltd. NVCR Downgrade Neutral
(Outperform)
70.99
(218.04)
207.14% Details
7/5/2019 Karyopharm Therapeutics KPTI Maintain Outperform
(N/A)
 
 
  Details
6/21/2019 AnaptysBio ANAB Maintain Outperform
(N/A)
 
 
  Details
6/18/2019 Voyager Therapeutics VYGR Maintain Outperform
(N/A)
 
 
  Details
6/17/2019 Blueprint Medicines BPMC Maintain Outperform
(N/A)
 
 
  Details
5/13/2019 Stemline Therapeutics STML Downgrade Neutral
(Outperform)
16.08
(13.03)
-18.97% Details
5/3/2019 Intellia Therapeutics NTLA Upgrade Outperform
(Neutral)
14.46
(15.51)
7.26% Details
5/3/2019 MacroGenics MGNX Upgrade Outperform
(Neutral)
16.78
(21.89)
30.45% Details
4/9/2019 Audentes Therapeutics BOLD Maintain Outperform
(N/A)
 
 
  Details
4/9/2019 Aravive Inc. ARAV New Coverage Outperform
(N/A)
6.97
(4.97)
-28.69% Details
4/9/2019 Aravive Inc. AVAV New Coverage Outperform
(N/A)
18.53
(109.81)
492.61% Details
3/18/2019 resTORbio Inc. TORC Maintain Outperform
(N/A)
 
 
  Details
3/12/2019 Kiniksa KNSA Maintain Outperform
(N/A)
 
 
  Details
3/12/2019 Mersana MRSN Maintain Outperform
(N/A)
 
 
  Details
3/11/2019 TCR2 Therapeutics TCRR New Coverage Outperform
(N/A)
18.02
(16.91)
-6.16% Details
3/5/2019 MyoKardia MYOK Maintain Outperform
(N/A)
 
 
  Details
3/4/2019 Nightstar Therapeutics NITE Downgrade Neutral
(Outperform)
15.16
(25.41)
67.61% Details
3/4/2019 Sutro Biopharma STRO Maintain Outperform
(N/A)
 
 
  Details
3/1/2019 NovoCure Ltd. NVCR Maintain Outperform
(N/A)
 
 
  Details
3/1/2019 argenx SE ARGX Maintain Outperform
(N/A)
 
 
  Details
2/27/2019 Karyopharm Therapeutics KPTI Maintain Outperform
(N/A)
 
 
  Details
2/26/2019 Xencor, Inc. XNCR Maintain Outperform
(N/A)
 
 
  Details
2/25/2019 Clementia Pharmaceuticals Inc. CMTA Downgrade Neutral
(Outperform)
14.94
(26.35)
76.37% Details
2/25/2019 Karyopharm Therapeutics KPTI Maintain Outperform
(N/A)
 
 
  Details
2/20/2019 Spark Therapeutics ONCE Maintain Neutral
(N/A)
 
 
  Details
2/7/2019 MacroGenics MGNX Downgrade Neutral
(Outperform)
25.60
(16.78)
-34.45% Details
1/30/2019 Voyager Therapeutics VYGR Maintain Outperform
(N/A)
 
 
  Details
1/22/2019 MacroGenics MGNX Maintain Outperform
(N/A)
 
 
  Details
1/2/2019 MyoKardia MYOK Maintain Outperform
(N/A)
 
 
  Details
12/4/2018 Tesaro TSRO Downgrade Neutral
(Outperform)
73.50
(74.96)
1.99% Details
11/26/2018 Orchard Therapeutics ORTX New Coverage Outperform
(N/A)
16.04
(4.84)
-69.83% Details
11/9/2018 AnaptysBio ANAB Maintain Outperform
(N/A)
 
 
  Details
11/9/2018 Karyopharm Therapeutics KPTI Upgrade Outperform
(Neutral)
11.92
(18.83)
57.97% Details
11/8/2018 Voyager Therapeutics VYGR Maintain Outperform
(N/A)
 
 
  Details
11/7/2018 Spark Therapeutics ONCE Upgrade Neutral
(Underperform)
44.02
(110.05)
150% Details
11/2/2018 Intellia Therapeutics NTLA Downgrade Neutral
(Outperform)
16.98
(14.46)
-14.84% Details
10/22/2018 Sutro Biopharma STRO New Coverage Outperform
(N/A)
14.55
(19.92)
36.91% Details
10/10/2018 Applied Genetic Technologies Corp. AGTC Maintain Outperform
(N/A)
 
 
  Details
10/8/2018 Audentes Therapeutics BOLD Maintain Outperform
(N/A)
 
 
  Details
9/26/2018 NovoCure Ltd. NVCR Maintain Outperform
(N/A)
 
 
  Details
9/25/2018 Nightstar Therapeutics NITE Maintain Outperform
(N/A)
 
 
  Details
9/20/2018 argenx SE ARGX Maintain Outperform
(N/A)
 
 
  Details
8/14/2018 Unum Therapeutics UMRX Maintain Outperform
(N/A)
 
 
  Details